Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Peking University First Hospital (Peking Univesity First Medical School)

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Sirolimus Monotherapy in the Treatment of Antiphospholipid Antibody Related Thrombocytopenia

Phase 4

Recruiting

Conditions: Antiphospholipid (aPL)-Positive
Thrombocytopaenia

Interventions: Drug: Sirolimus
Drug: Placebo

First Posted Date: 2024-12-09

Last Posted Date: 2025-04-30

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 84

Registration Number: NCT06722586

Locations: 🇨🇳
Xiangya Hospital of Central South University, Changsha, Hunan, China
🇨🇳
Qilu Hospital of Shandong University, Jinan, Shangdong, China
🇨🇳
West China Hospital, Sichuan University, Chengdu, Sichuan, China

and more 6 locations

A Molecular Probe Targeting BCMA for the Clinical Diagnosis of Multiple Myeloma

Early Phase 1

Recruiting

Conditions: Multiple Myeloma and Malignant Plasma Cell Neoplasms

Interventions: Drug: 68Ga-BC1
Drug: 18F-FDG

First Posted Date: 2024-12-04

Last Posted Date: 2025-06-06

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 50

Registration Number: NCT06717113

Locations: 🇨🇳
Department of Nuclear Medicine, Peking University First Hospital, Beijing, Beijing, China
🇨🇳
Peking University First Hospital, Beijing, Beijing, China

Evaluation of Targeted Biopsy Plus Sextant Biopsy in Diagnosis of Prostate Cancer

Not Applicable

Recruiting

Conditions: Prostate Cancer

First Posted Date: 2024-11-12

Last Posted Date: 2025-06-13

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 300

Registration Number: NCT06684652

Locations: 🇨🇳
Peking University First Hospital, Beijing, Beijing, China

SABR Combined with Targeted Therapy and Anti-PD-1 for Recurrent or Metastatic Renal Cancer

Recruiting

Conditions: Radiation Therapy
Metastatic Renal Cancer
Recurrent Renal Cell Cancer

Interventions: Radiation: Radiation therapy
Drug: Targeted and immunotherapy

First Posted Date: 2024-09-03

Last Posted Date: 2025-02-14

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 300

Registration Number: NCT06583070

Locations: 🇨🇳
Peking University First Hospital, Beijing, Beijing, China
🇨🇳
Peking University Third Hospital, Beijing, Beijing, China

Comprehensive Evaluation of MRI-AI in Prostate Cancer Diagnosis

Not Applicable

Recruiting

Conditions: Prostate Cancer

Interventions: Diagnostic Test: Combination of targeted biopsy and systematic biopsy

First Posted Date: 2024-08-28

Last Posted Date: 2024-08-28

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 1000

Registration Number: NCT06575361

Locations: 🇨🇳
Peking University First Hospital, Beijing, Beijing, China

Evaluating the Diagnostic Efficacy of Smartwatch and Smartphone for Sleep Apnea

Recruiting

Conditions: Sleep Apnea, Obstructive

First Posted Date: 2024-08-27

Last Posted Date: 2024-10-18

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 295

Registration Number: NCT06573372

Locations: 🇨🇳
Cheng Zhang, Beijing, Beijing, China

Mini-dose Dexmedetomidine-Esketamine Supplemented Analgesia in Patients at High-risk of OSA

Phase 4

Not yet recruiting

Conditions: Obstructive Sleep Apnea
Surgery
Dexmedetomidine
Esketamine
Postoperative Sleep Quality

Interventions: Drug: Dexmedetomidine-esketamine combination
Drug: Placebo

First Posted Date: 2024-08-22

Last Posted Date: 2024-08-22

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 100

Registration Number: NCT06566482

Locations: 🇨🇳
Peking University First Hospital, Beijing, Beijing, China

Dexmedetomidine-esketamine Combined Nasal Administration and Emergence Delirium

Phase 4

Not yet recruiting

Conditions: Nasal Administration
Esketamine
General Anesthesia
Dexmedetomidine
Older Patients
Emergence Delirium

Interventions: Drug: Normal saline
Drug: Dexmedetomidine
Drug: Esketamine

First Posted Date: 2024-08-22

Last Posted Date: 2024-08-22

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 340

Registration Number: NCT06566469

Locations: 🇨🇳
Peking University First Hospital, Beijing, Beijing, China

FAP-targeting PET/CT for Noninvasive Monitoring of Renal Fibrosis

Not Applicable

Conditions: Renal Fibrosis
CKD

Interventions: Other: FAP-targeting PET/CT imaging will be performed on the enrolled patients.

First Posted Date: 2024-08-21

Last Posted Date: 2024-08-21

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 90

Registration Number: NCT06563765

Locations: 🇨🇳
Peking University First Hospital, Beijing, Beijing, China

Incisional Negative Pressure Therapy to Prevent Animal Induced Wound Infection

Not Applicable

Not yet recruiting

Conditions: Wound Infection
Injury Caused by Animal Bites

Interventions: Device: incisional negative pressure wound technology

First Posted Date: 2024-08-19

Last Posted Date: 2024-08-19

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 60

Registration Number: NCT06558942

Locations: 🇨🇳
Emergency Department of Peking University First Hospital, Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy